Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa
2007
Legal Complexities of Enrolling Adolescents in HIV Vaccine Trials in South Africa
publication
Evidence: moderate
Author Information
Author(s): Catherine Slack, Ann Strode, Theodore Fleischer, Glenda Gray, Chitra Ranchod
Primary Institution: University of KwaZulu-Natal
Hypothesis
What are the legal complexities involved in enrolling adolescents in HIV vaccine trials in South Africa?
Conclusion
The article outlines essential legal and ethical considerations for conducting adolescent HIV vaccine trials in South Africa.
Supporting Evidence
- Adolescents are severely affected by the HIV epidemic and should be the main beneficiaries of a successful HIV vaccine.
- Current South African law lacks clear guidelines for adolescent participation in research.
- Consent processes must be designed to be sensitive to adolescent decision-making characteristics.
Takeaway
This study talks about the rules and laws that need to be followed when including teenagers in HIV vaccine tests in South Africa.
Limitations
The lack of a comprehensive ethical-legal framework for child research in South Africa poses challenges.
Participant Demographics
Adolescents aged 12-18, with a focus on those at high risk of HIV infection.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website